These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19415233)
1. The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro. Scholz H; Lund T; Dahle MK; Collins JL; Korsgren O; Wang JE; Foss A Diabetologia; 2009 Jul; 52(7):1352-62. PubMed ID: 19415233 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Lund T; Fosby B; Korsgren O; Scholz H; Foss A Transpl Int; 2008 Jul; 21(7):669-78. PubMed ID: 18346012 [TBL] [Abstract][Full Text] [Related]
3. Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro. Lund T; Mangsbo SM; Scholz H; Gjorstrup P; Tötterman TH; Korsgren O; Foss A Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):237-44. PubMed ID: 20119897 [TBL] [Abstract][Full Text] [Related]
4. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem; ; . PubMed ID: 20007976 [TBL] [Abstract][Full Text] [Related]